130 patients results plus the extra 44 samples from the follow up tests. 520 enrolled in phase II and the endpoint was reached at 130 patients.
Our clinical study designers determined that an additional 44 sputum samples from patients who have received a diagnosis of lung cancer but have not yet begun treatment would provide the data required to complete the Phase II trial.
Market Data 
Markets 
AI
